Analyst Ratings for PhaseBio Pharmaceuticals Inc. (PHAS)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.3 / 10 Percentile Rank: 30%
Rating Score: 3.3 / 10 Percentile Rank: 30%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/24/2022 | TD Cowen | Phil Nadeau | Downgrade | Hold (Buy) |
N/A (N/A) |
0.20 (0.07) |
-65% | Details |
9/28/2022 | Stifel | Annabel Samimy | Downgrade | Hold (Buy) |
1.00 (N/A) |
0.76 (0.07) |
-90.79% | Details |